OAC
RIGL icon

OMERS Administration Corp’s Rigel Pharmaceuticals RIGL Stock Holding History

OMERS Administration Corp’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$773K Buy
+28,600
New +$961K 0.01% 702
2025
Q4 		– Sell
-12,000
Closed -$340K – 1284
2025
Q3 		$340K Buy
+12,000
New +$359K ﹤0.01% 845

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMERS Administration Corp's RIGL Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Rigel Pharmaceuticals (RIGL) in Q1 2026: 28,600 shares worth $773K. The stake represents 0.01% of the portfolio and ranks #702 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in RIGL as recently as Q3 2025.

OMERS Administration Corp first reported a position in RIGL in Q3 2025 and has held it in 2 quarters since. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • OMERS Administration Corp held 28,600 shares of Rigel Pharmaceuticals worth $773K as of Q1 2026.
  • Rigel Pharmaceuticals was a new OMERS Administration Corp position in Q1 2026.
  • Rigel Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #702 holding.
  • OMERS Administration Corp first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.